ArticleBMC urology2014

Dutasteride plus tamsulosin fixed-dose combination first-line therapy versus tamsulosin monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting.

Maria Geitona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.